Distinct effects of two CD44 isoforms on tumor growth in vivo

doi:10.1084/jem.174.4.859

This Article

	Full Text (PDF, 2152K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Sy, M. S.
	Articles by Stamenkovic, I.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Sy, M. S.
	Articles by Stamenkovic, I.


Social Bookmarking

	What's this?

ARTICLES

Distinct effects of two CD44 isoforms on tumor growth in vivo

MS Sy, YJ Guo and I Stamenkovic
Department of Pathology, Massachusetts General Hospital, Charlestown, 02129.

Tumor growth is dependent in part on interactions between tumor cells and the extracellular matrix of host tissues. Expression of the cell surface glycoprotein CD44/Pgp-1, which mediates cell-substrate interactions is increased in many types of malignancies, but the role of CD44 in tumor growth is largely undefined. Recently, two isoforms of CD44 have been identified: an 80-90 kD form, which has high affinity for cell bound hyaluronate and a 150 kD form which does not mediate attachment to hyaluronate-coated surfaces. In this work, human B cell lymphoma cells stably transfected with cDNA clones encoding either of the two CD44 isoforms were compared for tumorigenicity and metastatic potential in nude mice. Expression of the 80-90 kD form but not the 150 kD form of CD44 greatly enhanced both local tumor formation and metastatic proclivity of the lymphoma cells. Our results suggest that CD44 polypeptides may play an important role in regulating primary and metastatic tumor development in vivo.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Wallach-Dayan, S. B., Rubinstein, A. M., Hand, C., Breuer, R., Naor, D. (2008). DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis. Molecular Cancer Therapeutics 7: 1615-1623 [Abstract] [Full Text]
McKallip, R. J., Fisher, M., Gunthert, U., Szakal, A. K., Nagarkatti, P. S., Nagarkatti, M. (2005). Role of CD44 and Its v7 Isoform in Staphylococcal Enterotoxin B-Induced Toxic Shock: CD44 Deficiency on Hepatic Mononuclear Cells Leads to Reduced Activation-Induced Apoptosis That Results in Increased Liver Damage. Infect. Immun. 73: 50-61 [Abstract] [Full Text]
Avin, E., Haimovich, J., Hollander, N. (2004). Anti-Idiotype x Anti-CD44 Bispecific Antibodies Inhibit Invasion of Lymphoid Organs by B Cell Lymphoma. J. Immunol. 173: 4736-4743 [Abstract] [Full Text]
Hayes, G. M., Chiu, R., Carpenito, C., Dougherty, S. T., Dougherty, G. J. (2002). Identification of Sequence Motifs Responsible for the Adhesive Interaction between Exon v10-containing CD44 Isoforms. J. Biol. Chem. 277: 50529-50534 [Abstract] [Full Text]
McKallip, R. J., Do, Y., Fisher, M. T., Robertson, J. L., Nagarkatti, P. S., Nagarkatti, M. (2002). Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int Immunol 14: 1015-1026 [Abstract] [Full Text]
Toole, B. P., Wight, T. N., Tammi, M. I. (2002). Hyaluronan-Cell Interactions in Cancer and Vascular Disease. J. Biol. Chem. 277: 4593-4596 [Full Text]
Yu, W.-H., Woessner, J. F. Jr., McNeish, J. D., Stamenkovic, I. (2002). CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16: 307-323 [Abstract] [Full Text]
Urquidi, V., Sloan, D., Kawai, K., Agarwal, D., Woodman, A. C., Tarin, D., Goodison, S. (2002). Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis. Clin. Cancer Res. 8: 61-74 [Abstract] [Full Text]
Fujimoto, T., Kawashima, H., Tanaka, T., Hirose, M., Toyama-Sorimachi, N., Matsuzawa, Y., Miyasaka, M. (2001). CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol 13: 359-366 [Abstract] [Full Text]
Wallach-Dayan, S. B., Grabovsky, V., Moll, J., Sleeman, J., Herrlich, P., Alon, R., Naor, D. (2001). CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. J. Cell Sci. 114: 3463-3477 [Abstract] [Full Text]
Lin, Y.-H., Huang, C.-J., Chao, J.-R., Chen, S.-T., Lee, S.-F., Yen, J. J.-Y., Yang-Yen, H.-F. (2000). Coupling of Osteopontin and Its Cell Surface Receptor CD44 to the Cell Survival Response Elicited by Interleukin-3 or Granulocyte-Macrophage Colony-Stimulating Factor. Mol. Cell. Biol. 20: 2734-2742 [Abstract] [Full Text]
Drillenburg, P., Pals, S. T. (2000). Cell adhesion receptors in lymphoma dissemination. Blood 95: 1900-1910 [Abstract] [Full Text]
Yu, Q., Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163-176 [Abstract] [Full Text]
Okamoto, I., Kawano, Y., Matsumoto, M., Suga, M., Kaibuchi, K., Ando, M., Saya, H. (1999). Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins. J. Biol. Chem. 274: 25525-25534 [Abstract] [Full Text]
Hurt-Camejo, E., Rosengren, B., Sartipy, P., Elfsberg, K., Camejo, G., Svensson, L. (1999). CD44, a Cell Surface Chondroitin Sulfate Proteoglycan, Mediates Binding of Interferon-gamma and Some of Its Biological Effects on Human Vascular Smooth Muscle Cells. J. Biol. Chem. 274: 18957-18964 [Abstract] [Full Text]
Itano, N., Sawai, T., Miyaishi, O., Kimata, K. (1999). Relationship between Hyaluronan Production and Metastatic Potential of Mouse Mammary Carcinoma Cells. Cancer Res. 59: 2499-2504 [Abstract] [Full Text]
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., Jackson, D. G. (1999). LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan. JCB 144: 789-801 [Abstract] [Full Text]
Yu, Q., Stamenkovic, I. (1999). Localization of matrix metalloproteinase 9�to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13: 35-48 [Abstract] [Full Text]
Sterling, H., Saginario, C., Vignery, A. (1998). CD44 Occupancy Prevents Macrophage Multinucleation. JCB 143: 837-847 [Abstract] [Full Text]
Rachmilewitz, J., Tykocinski, M. L. (1998). Differential Effects of Chondroitin Sulfates A and B on Monocyte and B-Cell Activation: Evidence for B-Cell Activation Via a CD44-Dependent Pathway. Blood 92: 223-229 [Abstract] [Full Text]
Yakushijin, Y., Steckel, J., Kharbanda, S., Hasserjian, R., Neuberg, D., Jiang, W.-m., Anderson, I., Shipp, M. A. (1998). A Directly Spliced Exon 10-Containing CD44 Variant Promotes the Metastasis and Homotypic Aggregation of Aggressive Non-Hodgkin's Lymphoma. Blood 91: 4282-4291 [Abstract] [Full Text]
Sherman, L., Wainwright, D., Ponta, H., Herrlich, P. (1998). A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb�outgrowth. Genes Dev. 12: 1058-1071 [Abstract] [Full Text]
Yu, Q., Toole, B. P., Stamenkovic, I. (1997). Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function. JEM 186: 1985-1996 [Abstract] [Full Text]
Sleeman, J. P., Kondo, K., Moll, J., Ponta, H., Herrlich, P. (1997). Variant Exons v6 and v7 Together Expand the Repertoire of Glycosaminoglycans Bound by CD44. J. Biol. Chem. 272: 31837-31844 [Abstract] [Full Text]
Kogerman, P., Sy, M.-S., Culp, L. A. (1997). Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: Facilitated retention in the lung�vasculature. Proc. Natl. Acad. Sci. USA 94: 13233-13238 [Abstract] [Full Text]
Schmits, R., Filmus, J., Gerwin, N., Senaldi, G., Kiefer, F., Kundig, T., Wakeham, A., Shahinian, A., Catzavelos, C., Rak, J., Furlonger, C., Zakarian, A., Simard, J. J.L., Ohashi, P. S., Paige, C. J., Gutierrez-Ramos, J. C., Mak, T. W. (1997). CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity. Blood 90: 2217-2233 [Abstract] [Full Text]
Kaya, G, Rodriguez, I, Jorcano, J L, Vassalli, P, Stamenkovic, I (1997). Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.. Genes Dev. 11: 996-1007 [Abstract]
Taylor, D. D., Gercel-Taylor, C., Gall, S. A. (1996). Expression and Shedding of CD44 Variant Isoforms in Patients With Gynecologic Malignancies. Reproductive Sciences 3: 289-294 [Abstract]
Takahashi, K., Stamenkovic, I., Cutler, M., Dasgupta, A., Tanabe, K. K. (1996). Keratan Sulfate Modification of CD44 Modulates Adhesion to Hyaluronate. J. Biol. Chem. 271: 9490-9496 [Abstract] [Full Text]
Taher, T. E. I., Smit, L., Griffioen, A. W., Schilder-Tol, E. J. M., Borst, J., Pals, S. T. (1996). Signaling through CD44 Is Mediated by Tyrosine Kinases. J. Biol. Chem. 271: 2863-2867 [Abstract] [Full Text]
Goebeler, M, Kaufmann, D, Brocker, E., Klein, C. (1996). Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J. Cell Sci. 109: 1957-1964 [Abstract]
Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y., Kitamura, F., Yagita, H., Suzuki, K., Miyasaka, M. (1995). A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan. J. Biol. Chem. 270: 7437-7444 [Abstract] [Full Text]
Bartolazzi, A, Jackson, D, Bennett, K, Aruffo, A, Dickinson, R, Shields, J, Whittle, N, Stamenkovic, I (1995). Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J. Cell Sci. 108: 1723-1733 [Abstract]
The International Non-Hodgkin's Lymphoma Prognosti, (1993). A Predictive Model for Aggressive Non-Hodgkin's Lymphoma. NEJM 329: 987-994 [Abstract] [Full Text]
Wheatley, S., Isacke, C., Crossley, P. (1993). Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119: 295-306 [Abstract]
Hua, Q, Knudson, C., Knudson, W (1993). Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell Sci. 106: 365-375 [Abstract]
Kennel, S., Lankford, T., Foote, L., Shinpock, S., Stringer, C (1993). CD44 expression on murine tissues. J. Cell Sci. 104: 373-382 [Abstract]
Underhill, C. (1992). CD44: the hyaluronan receptor. J. Cell Sci. 103: 293-298